It is more than a year since the Dag Hammarskjöld Seminar at Bogève and in Geneva. We have tried our best to retain the spirit of those important discussions while updating the information. The pace of technical, political and corporate change makes both the data and the analysis something of a moving target. No doubt we have sometimes missed our mark.
Another Development and the New Biotechnologies